-
Study aim
-
Comparative study of the success rate and complications of abdominal sacrohysteropexy with abdominal uterosacral
-
Design
-
This is a non-blinded randomized clinical trial with a parallel design. It will be conducted on 15 women candidates for surgery. A random block is used for randomization and the participants are assigned to two intervention groups.
-
Settings and conduct
-
In this unblinded study, patients are treated with enoxaparin subcutaneously 12 hours before surgery and two grams of Keflin are injected as prophylaxis half an hour before surgery.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Informed consent; Patients with complaints of uterine-vaginal prolapse who want to preserve the uterus
Exclusion criteria: Urinary incontinence; History of pelvic prolapse surgery
Malignancy or dysplasia on Pap smear; Immune system disorders, blood or coagulation disorders
-
Intervention groups
-
In the first intervention group, after entering the abdomen, the sigmoid colon is pushed aside, and the location of the ureters is determined. The peritoneum is pushed aside on the promontory of the sacrum. In the area of the cervix and the back of the uterus, after separating the serous tissue, a polypropylene mesh with dimensions of 5 x 15 cm is connected to the back of the cervix and uterus and is connected to the promontory of the sacrum, and finally, the abdominal layers are closed. In the second intervention group, after opening the abdominal layers, the location of the uterosacral ligaments is determined, it is carefully separated from the ureters, and the uterus is connected to the uterosacral ligaments. Before closing the abdominal layers, the health of the ureters is ensured by performing a cystoscope, and then the abdominal layers are repaired in anatomical order.
-
Main outcome variables
-
The success of middle compartment surgery (bleeding rate, dyspareunia after surgery)